Literature DB >> 22151650

Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke.

Karin M Henriksson1, Bahman Farahmand, Signild Åsberg, Nils Edvardsson, Andreas Terént.   

Abstract

BACKGROUND: Differences in risk factor profiles between patients with ischemic and hemorrhagic stroke may have an impact on subsequent mortality. AIM: To explore cardiovascular disease risk factors, including the CHADS(2) score, with survival after ischemic or hemorrhagic stroke.
METHODS: Between 2001 and 2005, 87 111 (83%) ischemic stroke, 12 497 (12%) hemorrhagic stroke, and 5435 (5%) patients with unspecified stroke were identified in the Swedish Stroke Register. Data on gender, age, and cardiovascular disease risk factors were linked to the Swedish Hospital Discharge and Cause of Death Registers. Adjusted odds and hazard ratios and 95% confidence interval were calculated using logistic and Cox proportional hazard regression models.
RESULTS: Hemorrhagic stroke patients were younger than ischemic stroke patients. All cardiovascular disease risk factors studied, alone or combined in the CHADS(2) score, were associated with higher odds ratios for ischemic stroke vs. hemorrhagic stroke. Higher CHADS(2) scores and all studied risk factors except hypertension were associated with higher odds ratio for death by ischemic stroke than hemorrhagic stroke. Ischemic stroke was associated with lower early mortality (within 30 days) vs. hemorrhagic stroke (hazard ratio = 0·28, confidence interval 0·27 to 0·29).
CONCLUSIONS: Patients with hemorrhagic stroke had a higher risk of dying within the first 30 days after stroke, but the risk of death was similar in the two groups after one-month. Hypertension was the only cardiovascular disease risk factor associated with an increased mortality rate for hemorrhagic stroke as compared to ischemic stroke.
© 2011 The Authors. International Journal of Stroke © 2011 World Stroke Organization.

Entities:  

Mesh:

Year:  2011        PMID: 22151650     DOI: 10.1111/j.1747-4949.2011.00706.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  15 in total

1.  Severity of Hypertension Correlates with Risk of Thromboembolic Stroke.

Authors:  Hui Pang; Bing Han; Qiang Fu; Qiumei Cao
Journal:  J Cardiovasc Transl Res       Date:  2017-05-31       Impact factor: 4.132

Review 2.  Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.

Authors:  Karsten Mh Bruins Slot; Eivind Berge
Journal:  Cochrane Database Syst Rev       Date:  2018-03-06

3.  Implementation of telephone-based secondary preventive intervention after stroke and transient ischemic attack - participation rate, reasons for nonparticipation and one-year mortality.

Authors:  Anna-Lotta Irewall; Lisa Bergström; Joachim Ogren; Katarina Laurell; Lars Söderström; Thomas Mooe
Journal:  Cerebrovasc Dis Extra       Date:  2014-02-19

4.  Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.

Authors:  Francois-Emery Cotté; Gwendoline Chaize; Anne-Françoise Gaudin; Adeline Samson; Alexandre Vainchtock; Laurent Fauchier
Journal:  Europace       Date:  2015-12-30       Impact factor: 5.214

5.  Therapeutic experience of 289 elderly patients with biliary diseases.

Authors:  Zong-Ming Zhang; Zhuo Liu; Li-Min Liu; Chong Zhang; Hong-Wei Yu; Bai-Jiang Wan; Hai Deng; Ming-Wen Zhu; Zi-Xu Liu; Wen-Ping Wei; Meng-Meng Song; Yue Zhao
Journal:  World J Gastroenterol       Date:  2017-04-07       Impact factor: 5.742

6.  Comparison of transesophageal echocardiography findings after different anticoagulation strategies in patients with atrial fibrillation: a systematic review and meta-analysis.

Authors:  Jian Yang; Xuan Zhang; Xi-Ying Wang; Chi Zhang; Song-Zan Chen; Shen-Jiang Hu
Journal:  BMC Cardiovasc Disord       Date:  2019-11-26       Impact factor: 2.298

7.  Effect of Evidence-Based Pharmacy Care on Satisfaction and Cognition in Patients with Non-Valvular Atrial Fibrillation Taking Rivaroxaban.

Authors:  Jie Sun; Guo-Mei Chen; Ji Huang
Journal:  Patient Prefer Adherence       Date:  2021-07-25       Impact factor: 2.711

8.  A protocol for a prospective observational study using chest and thumb ECG: transient ECG assessment in stroke evaluation (TEASE) in Sweden.

Authors:  Peter Magnusson; Hirsh Koyi; Gustav Mattsson
Journal:  BMJ Open       Date:  2018-04-03       Impact factor: 2.692

9.  Antithrombotic treatments in patients with acute ischemic stroke and non-valvular atrial fibrillation before introduction of non-vitamin K antagonist oral anticoagulants into practice in Korea.

Authors:  Hee-Joon Bae; Ji Hoe Heo; Keun-Hwa Jung; Yong-Seok Lee; Keun-Sik Hong; Woo-Keun Seo; Jaseong Koo; Jae-Kwan Cha; Mi Ji Lee; Bo-Jeong Seo; Young-Joo Kim; Seongsik Kang; Jinmi Seok; Juneyoung Lee; Chin-Sang Chung
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

10.  Socioeconomic status and survival after stroke - using mediation and sensitivity analyses to assess the effect of stroke severity and unmeasured confounding.

Authors:  Anita Lindmark; Bo Norrving; Marie Eriksson
Journal:  BMC Public Health       Date:  2020-04-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.